PHILADELPHIA, Pennsylvania, Dec. 3 -- Cancer Discovery, a peer-reviewed journal from the American Association for Cancer Research that says it describes major advances in research and clinical trials, published six research articles, including the following topics, in its December 2019 edition:

* First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

* GATA3-Controlled Nucleosome Eviction Dr . . .

Click here for more information about our products